Aim: To test the hypothesis that oxytocin nasal spray increases early milk output in mothers expressing milk for preterm infants. Methods: A randomised, double blind trial of oxytocin nasal spray (100 ...

The protective effect was enhanced by delivering the antibody in a nasal spray that disperses these molecules throughout ... is based on the IgM version of an immunoglobulin antibody, the generic ...

An NHS doctor has warned specific people against using nasal sprays, warning that doing so could induce "horrible" symptoms. Nasal decongestants are widely sought after for those needing respite ...

Certain people have been warned against using nasal sprays by an NHS doctor. According to the expert, doing so could result in some “horrible” symptoms. Nasal decongestants can be a much ...

Institute of Nano Science and Technology (INST), Knowledge City, Sector-81, SAS Nagar, Mohali 140306, Punjab, India ...

The protective effect was enhanced by delivering the antibody in a nasal spray that disperses these ... version of an immunoglobulin antibody, the generic first line of antibody defense against ...

In this episode, host Tylah Tully looks at news from LTR Pharma (ASX:LTP) who have signed a collaborative agreement with Strategic Drug Solutions to develop a novel-treatment for oesophageal motility ...

LYR-210 is a bioabsorbable nasal implant designed to be inserted in a simple, in-office procedure. LYR-210 is intended to deliver six months of continuous anti-inflammatory therapy, mometasone furoate ...

The US Food and Drug Administration (FDA) has approved dihydroergotamine (DHE) nasal powder (Atzumi, Satsuma Pharmaceuticals Inc) for the acute treatment of migraine with or without aura in adults ...

to co-promote neffy ® (epinephrine nasal spray), the only approved needle-free treatment for Type I allergic reactions including anaphylaxis, to up to 9,000 pediatricians. This agreement ...

The recommended dose of Atzumi is 5.2 mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine ...